Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... Company

A world free of pain. This is our shared vision. To bring it to life, we execute our strategy and work on our company’s culture – everyday, everywhere, every one of us.

... We are Grünenthal

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

The Supervisory Board advises and controls the Corporate Executive Board and is elected by the shareholders’ summit.

... Supervisory Board

Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... Partnering

In view of our vision of a World Free of Pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Grünenthal’s product portfolio, brands, ingredients and indication range.

... Products

Explore our media section and access a range of materials relating to our company, people, medicines and medical devices.

... Media

Grünenthal is a global leader in pain management and related diseases. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain. Explore our recent stories to see what drives us.

... Our Stories

In this section you will find both current and archived press releases published from 2013 onwards by Grünenthal GmbH, Germany.

... Press releases

... Statements

Journalists are invited to use our corporate publications for their reporting. The list contains business related publication like the company presentation or the code of conduct. .

... Corporate publications

Journalists are invited to use images from our library to illustrate their reporting. The library contains company and R&D related pictures.

... Image resources

The library contains a set of company footage. Journalists are invited to use the video material to illustrate their reporting.

... Video resources

Corporate profile

Grünenthal is a global leader in pain management and related disease.

We have a long track record of bringing innovative treatments to patients worldwide. As a fully integrated pharmaceutical company, we cover the entire value chain – from drug research and development to commercialisation of portfolios with growth products and established medicines. We operate in accordance with the highest ethical and regulatory standards, and we focus our efforts on our vision of a World Free of Pain.

Grünenthal at a glance

Our virtual company showcase provides information about our key objectives and activities, as well as our recent business development highlights and financial performance.

Enter

keywords

Strong and capable team

4,400

employees worldwide

Solid revenue base

1.8

billion euros in 2023

Commercial presence in

27

countries across Europe, Latin America, and the US

Products sold in around

100

countries

International network

2

R&D sites – one R&D Unit in Aachen (Germany) and an Innovation Hub in Boston, (USA)

Production capacities

5

manufacturing sites in Europe and Latin America

Elderly female patient with crutches

Our unique commitment

Pain is a huge burden. It impacts patients – as well as their families, friends, caregivers and society as a whole. 75 years of developing innovative medicines for patients, we are driven to seek new solutions to relieve pain.

Our Vision: A World Free of Pain

Responsibility

Responsibility

At Grünenthal, conducting our business responsibly is a core part of our company’s strategy and culture. As a global leader in pain management, Grünenthal aspires to create a positive impact for society – in our core business and beyond. We are guided by integrity, transparency and the highest ethical standards.

Responsibility: A core part of our company’s strategy and culture

Contract Manufacturing GRT PRO

Global capabilities

Although firmly rooted in Germany, today we are very much a growing global business: since spreading our wings beyond Germany in the 1960s, we have continued to grow steadily and expand our market presence and product portfolio. We collaborate with commercial partners and multiple stakeholders from the pain management field and beyond in order to make our medicines available to patients.

Explore our global presence and sites

Pipeline

Pipeline

To move closer to our vision of a world free of pain, we are currently pursuing a range of programs across different modalities, targets, and mechanisms of action. Here are some selected highlights from our development pipeline: RTX (resiniferatoxin), MPC-06-ID, Glucocorticoid Receptor Modulator (GRM), Nociceptin/Orphanin FQ receptor Peptide agonist (NOP).

Explore Grünenthal's development pipeline